InMode

INMD Small Cap

Healthcare · Medical Devices

Updated: Apr 5, 2026, 17:43 UTC

$13.79

+0.66% today

52W: $12.72 – $16.74

52W Low: $12.72 Position: 26.6% 52W High: $16.74

🔗 Compare Brokers

Key Metrics

P/E Ratio

9.64x

Price-to-Earnings

Forward P/E

9.01x

Forward Price/Earnings

P/S Ratio

2.36x

Price-to-Sales

EV/EBITDA

3.79x

Enterprise Value/EBITDA

Div. Yield

—

Annual dividend yield

Market Cap

$873.7M

Market Capitalization

Revenue Growth

6.1%

YoY Revenue Growth

Profit Margin

25.33%

Net profit margin

ROE

13.53%

Return on Equity

Beta

2.12

Market sensitivity

Short Interest

5.83%

% of float sold short

Avg. Volume

1,135,578

Average daily volume

Valuation Analysis

Signal

Undervalued

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Hold

4 analysts

Avg. Price Target

$17.00

+23.28% upside

Target Range

$15.00 – $21.00

About the Company

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearanc

Sector: Healthcare Industry: Medical Devices Country: Israel Employees: 660 Exchange: NMS